Shandong Buchang Pharmaceuticals Co (SHSE:603858) Cyclically Adjusted FCF per Share: ¥0.92 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603858 Shandong Buchang Pharmaceuticals Co Ltd SHSE:603858
70 GF Score
Price ¥15.95
GF Value ¥15.93
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Shandong Buchang Pharmaceuticals Co Cyclically Adjusted FCF per Share?

Shandong Buchang Pharmaceuticals Co SHSE:603858 +3.37% 70 Cyclically Adjusted FCF per Share is ¥0.92 as of Mar. 2026. GuruFocus rates SHSE:603858 with a GF Score™ of 70/100 and a GF Value™ of ¥15.93 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Shandong Buchang Pharmaceuticals Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was ¥-0.049. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.92 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-08), Shandong Buchang Pharmaceuticals Co's current stock price is ¥15.95. Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ¥0.92. Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF of today is 17.34.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Shandong Buchang Pharmaceuticals Co was 21.21. The lowest was 15.62. And the median was 18.33.


Shandong Buchang Pharmaceuticals Co  (SHSE:603858) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=15.95/0.92
=17.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Shandong Buchang Pharmaceuticals Co was 21.21. The lowest was 15.62. And the median was 18.33.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Shandong Buchang Pharmaceuticals Co Cyclically Adjusted FCF per Share Related Terms


Shandong Buchang Pharmaceuticals Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Buchang Pharmaceuticals Co Cyclically Adjusted FCF per Share Chart

Shandong Buchang Pharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.88 0.90

Shandong Buchang Pharmaceuticals Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.92 0.92 0.89 0.90 0.92

SHSE:603858 vs ZTS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Buchang Pharmaceuticals Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:603858
70GF Score
Shandong Buchang Pharmaceuticals Co Ltd SHSE:603858
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Buchang Pharmaceuticals Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shandong Buchang Pharmaceuticals Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.049/116.3033*116.3033
=-0.049

Current CPI (Mar. 2026) = 116.3033.

Shandong Buchang Pharmaceuticals Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.756 101.400 0.867
201609 0.292 102.400 0.332
201612 0.086 102.600 0.097
201703 0.267 103.200 0.301
201706 0.371 103.100 0.419
201709 -0.328 104.100 -0.366
201712 0.054 104.500 0.060
201803 -0.049 105.300 -0.054
201806 0.493 104.900 0.547
201809 0.348 106.600 0.380
201812 -0.433 106.500 -0.473
201903 0.482 107.700 0.521
201906 0.685 107.700 0.740
201909 0.146 109.800 0.155
201912 0.438 111.200 0.458
202003 0.087 112.300 0.090
202006 0.537 110.400 0.566
202009 0.400 111.700 0.416
202012 0.262 111.500 0.273
202103 0.188 112.662 0.194
202106 0.078 111.769 0.081
202109 0.042 112.215 0.044
202112 0.494 113.108 0.508
202203 0.201 114.335 0.204
202206 0.852 114.558 0.865
202209 0.676 115.339 0.682
202212 0.270 115.116 0.273
202303 -0.158 115.116 -0.160
202306 0.175 114.558 0.178
202309 -0.738 115.339 -0.744
202312 0.065 114.781 0.066
202403 -0.012 115.227 -0.012
202406 0.345 114.781 0.350
202409 0.139 115.785 0.140
202412 0.216 114.893 0.219
202503 0.604 115.116 0.610
202506 0.242 114.907 0.245
202509 -0.157 115.471 -0.158
202512 0.290 115.832 0.291
202603 -0.049 116.303 -0.049

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥0.92 mean?
Shandong Buchang Pharmaceuticals Co (SHSE:603858) has a Cyclically Adjusted FCF per Share of ¥0.92 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Shandong Buchang Pharmaceuticals Co and its competitors.
Is Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted FCF per Share too high?
Shandong Buchang Pharmaceuticals Co's current Cyclically Adjusted FCF per Share is ¥0.92. Overall, Shandong Buchang Pharmaceuticals Co has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted FCF per Share compare to ZTS?
Shandong Buchang Pharmaceuticals Co's Cyclically Adjusted FCF per Share of ¥0.92 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Shandong Buchang Pharmaceuticals Co and its competitors. Shandong Buchang Pharmaceuticals Co's current Cyclically Adjusted FCF per Share is ¥0.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Buchang Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Buchang Pharmaceuticals Co (SHSE:603858) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.93, compared to a current price of ¥15.95 — trading 0.1% above its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥0.92. Shandong Buchang Pharmaceuticals Co's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Shandong Buchang Pharmaceuticals Co (SHSE:603858), the current Cyclically Adjusted FCF per Share is ¥0.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Buchang Pharmaceuticals Co (SHSE:603858) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Buchang Pharmaceuticals Co stock appears to be overvalued. The current stock price of ¥15.95 is trading 0.1% above its estimated GF Value™ of ¥15.93. GuruFocus considers Shandong Buchang Pharmaceuticals Co to be Fairly Valued.

Key valuation signals for SHSE:603858:

  • Cyclically Adjusted FCF per Share: ¥0.92
  • GF Value™: ¥15.93 vs. price of ¥15.95 (0.1% above fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the SHSE:603858 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Buchang Pharmaceuticals Co Business Description

Address No. 369, Zhonghua West Road, Shandong Province, Heze, CHN, 274000
Shandong Buchang Pharmaceuticals Co Ltd is engaged in research and development, production and sales of Chinese patent medicines.
70GF Score

Get the complete analysis for SHSE:603858

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.95
Price
¥15.93
GF Value